Company Overview

Hyperion Therapeutics is a privately held pharmaceutical company focused on the development of treatments that address critical unmet needs in the areas of gastroenterology and hepatology.

Learn More

Clinical Trials

Hyperion Therapeutics is currently conducting clinical trials in two areas:

  • urea cycle disorders
    (phase III)
  • hepatic encephalopathy
    (phase II)

Read more about our current Clinical Trials